Salona Global Medical Device Corporation

Symbol: SGMD.V

TSX

0.22

CAD

Market price today

  • -15.8062

    P/E Ratio

  • 0.2483

    PEG Ratio

  • 17.24M

    MRK Cap

  • 0.00%

    DIV Yield

Salona Global Medical Device Corporation (SGMD-V) Stock Price & Analysis

Shares Outstanding

0M

Gross Profit Margin

0.36%

Operating Profit Margin

-0.08%

Net Profit Margin

-0.02%

Return on Assets

-0.02%

Return on Equity

-0.08%

Return on Capital Employed

-0.17%

Company general description and statistics

Sector: Healthcare
Industry: Medical Devices
CEO:Mr. Michael Seckler
Full-time employees:144
City:Del Mar
Address:3330 Caminito Daniella
IPO:2014-03-31
CIK:

Salona Global Medical Device Corporation, through its subsidiaries, engages in the production and sale of medical devices and products in the United States. The company's medical devices are used for pain management, cold and hot therapy, transcutaneous electronic nerve and neuromuscular electrical stimulation, pulsed electromagnetic field technology, and ultrasound therapy. It also offers wearable technology and products that are used to enhance physical stability. The company was formerly known as Brattle Street Investment Corp. and changed its name to Salona Global Medical Device Corporation in December 2020. Salona Global Medical Device Corporation was incorporated in 2013 and is headquartered in Del Mar, California.

General Outlook

When we look at how much money they make before expenses, they keep 0.357% as profit. This shows they're good at controlling costs and are financially stable. Their operating profit, which is money made from regular business activities, is -0.080%. This means they run their business efficiently. Lastly, after paying all their bills, they still have a profit of -0.023%. This tells us they're good at keeping money after all costs.

Return on Investments

The company's asset efficiency, represented by a robust -0.019% return, is a testament to Salona Global Medical Device Corporation's adeptness in optimizing resource deployment. Salona Global Medical Device Corporation's utilization of its assets to generate profits is strikingly evident through a noteworthy return on equity of -0.081%. Furthermore, the proficiency of Salona Global Medical Device Corporation in capital utilization is underscored by a remarkable -0.165% return on capital employed.

Stock Prices

Salona Global Medical Device Corporation's stock prices have been subject to undulating patterns. The peak stock value during this interval surged to $0.225, while its low point bottomed out at $0.22. This variance in figures offers investors a lucid insight into the roller-coaster ride that is Salona Global Medical Device Corporation's stock market.

Liquidity Ratios

Analyzing SGMD.V liquidity ratios reveals its financial health of the firm. The current ratio of 63.42% gauges short-term asset coverage for liabilities. The quick ratio (33.10%) assesses immediate liquidity, while the cash ratio (2.63%) indicates cash reserves.

cards.indicatorcards.value
Current Ratio63.42%
Quick Ratio33.10%
Cash Ratio2.63%

Profitability Ratios

SGMD.V profitability indicators offer a lens into its earnings landscape. A pretax profit margin of -2.32% underscores its earnings before tax deductions. The effective tax rate stands at 1.03%, revealing its tax efficiency. The net income per EBT, 98.97%, and the EBT per EBIT, 28.94%, provide insights into its earnings hierarchy. Lastly, with an EBIT per revenue ratio of -8.01%, we grasp its operational profitability.

cards.indicatorcards.value
Pretax Profit Margin-2.32%
Effective Tax Rate1.03%
Net Income per EBT98.97%
EBT per EBIT28.94%
EBIT per Revenue-8.01%

Operational Efficiency

Operational metrics shed light on its business agility. With an operating cycle of 0.63, it details the span from stock purchase to revenue.

cards.indicatorcards.value
Days of Sales Outstanding33
Days of Inventory Outstanding120
Operating Cycle197.25
Days of Payables Outstanding72
Cash Conversion Cycle126
Receivables Turnover4.71
Payables Turnover5.10
Inventory Turnover3.05
Fixed Asset Turnover3.75
Asset Turnover0.85

Cash Flow Ratios

Peering into the cash flow metrics reveals liquidity and operational efficiency. The operating cash flow per share, -0.01, and free cash flow per share, -0.02, depict cash generation on a per-share basis. The cash per share value, 0.01, showcases liquidity position. Lastly, the operating cash flow sales ratio, -0.02, offers insight into cash flow relative to sales.

cards.indicatorcards.value
Operating Cash Flow per Share-0.01
Free Cash Flow per Share-0.02
Cash per Share0.01
Operating Cash Flow Sales Ratio-0.02
Free Cash Flow to Operating Cash Flow Ratio1.55
Cash Flow Coverage Ratio-0.03
Short Term Coverage Ratio-0.05
Capital Expenditure Coverage Ratio-1.83
Dividend Paid and Capex Coverage Ratio-1.83

Debt and Leverage Ratios

Diving into debt and leverage metrics unveils the company's financial structure. The debt ratio, at 39.99%, highlights its total liabilities relative to assets. With a debt-equity ratio of 1.40, we discern the balance between debt and equity financing. The long-term debt to capitalization, 30.44%, and total debt to capitalization, 58.33%, ratios shed light on its capital structure. An interest coverage of -2.88 indicates its ability to manage interest expenses.

cards.indicatorcards.value
Debt Ratio39.99%
Debt Equity Ratio1.40
Long Term Debt to Capitalization30.44%
Total Debt to Capitalization58.33%
Interest Coverage-2.88
Cash Flow to Debt Ratio-0.03
Company Equity Multiplier3.50

Growth Ratios

Delving into growth metrics provides a snapshot of financial expansion. The revenue growth rate, 54686.90%, indicates top-line expansion, while the gross profit growth, 17872.28%, reveals profitability trends. EBIT growth, -334.71%, and operating income growth, -334.71%, offer insights into operational profitability progression. The net income growth, -63.90%, showcases bottom-line expansion, and the EPS growth, -63.67%, measures the growth in earnings per share.

cards.indicatorcards.value
Revenue Growth54686.90%
Gross Profit Growth17872.28%
EBIT Growth-334.71%
Operating Income Growth-334.71%
Net Income Growth-63.90%
EPS Growth-63.67%
EPS Diluted Growth-63.67%
Operating Cash Flow Growth-279.82%
Free Cash Flow Growth-285.48%
5-Year Revenue Growth per Share215.62%
3-Year Revenue Growth per Share350.64%
5-Year Operating CF Growth per Share-171.05%
3-Year Operating CF Growth per Share-171.69%
5-Year Net Income Growth per Share65.68%
3-Year Net Income Growth per Share-345.16%
5-Year Shareholders Equity Growth per Share-54.54%
3-Year Shareholders Equity Growth per Share-9.15%
5-Year Dividend per Share Growth per Share-100.00%
Receivables Growth5088.95%
Asset Growth225.07%
Book Value per Share Growth98.04%
SGA Expenses Growth478.44%

Valuation Ratios

Exploring the valuation ratios offers insights into perceived market value. The price to book value ratio, 1.07, and the price to book ratio, 1.07, reflect the market's valuation relative to the company's book value. The price to sales ratio, 0.30, provides a perspective on valuation in relation to sales. Ratios like price to free cash flows, -12.08, and price to operating cash flows, -22.56, gauge market valuation against cash flow metrics.

cards.indicatorcards.value
Price Book Value Ratio1.07
Price to Book Ratio1.07
Price to Sales Ratio0.30
Price Cash Flow Ratio-22.56
Price Earnings to Growth Ratio0.25
Enterprise Value Multiple14.49
Price Fair Value1.07
Price to Operating Cash Flow Ratio-22.56
Price to Free Cash Flows Ratio-12.08
security
Trusted project
“All information displayed on the site is verified. High quality project and financial performance”
Eugene Alexeev
NumFin Founder and investing enthusiast

Frequently Asked Question

How many company shares are outstanding in 2024?

There are stock number shares outstanding of Salona Global Medical Device Corporation (SGMD.V) on the TSX in 2024.

What is P/E ratio of enterprise in 2024?

The current P/E ratio of enterprise is -15.806 in 2024.

What is the ticker symbol of Salona Global Medical Device Corporation stock?

The ticker symbol of Salona Global Medical Device Corporation stock is SGMD.V.

What is company IPO date?

IPO date of Salona Global Medical Device Corporation is 2014-03-31.

What is company current share price?

Current share price is 0.220 CAD.

What is stock market cap today?

The market cap of stock today is 17241486.000.

What is PEG ratio in 2024?

The current 0.248 is 0.248 in 2024.

What is the number of employees in 2024?

In 2024 the company has 144.